QUiCKR Case Studies
Focus on your results, run QC workflows seamlessly
See how leading cell & gene therapy teams implement QUiCKR to cut turnaround times, reduce genomics spend, and accelerate their path to IND.
Cutting potency analysis from 5 days to 20 minutes
A leading Boston Biotech needed to screen 24 LNP dosages to determine editing efficiency across multiple nuclease conditions. NGS turnaround was the rate-limiting step — consuming 70% of their QC budget and slowing iteration to once per week. With QUiCKR this team was able to 5x the throughput/week and reduce their spend by 75%.
AAV titer QC in 1 hour for process development scale-up
A Gene Therapy CDMO running AAV manufacturing for multiple client programs needed rapid in-process controls. Their ddPCR workflow required 8 hours and specialized operators. QUiCKR Vector QC gave them same-hour QC decisions and 5x more throughput — without adding instruments or headcount.
Catching genomic abnormalities at every iPSC passage — before they compound
A clinical-stage cell therapy company manufacturing iPSC-derived products needed to monitor chromosomal integrity at each passage during process development. Traditional karyotyping took 10 days per lot, meaning abnormalities were often detected only after multiple downstream passages — too late to course-correct without significant rework.